Polyethylene glycol–gum acacia-based multidrug delivery system for controlled delivery of anticancer drugs

被引：0
作者：
V. O. Fasiku
B. A. Aderibigbe
E. R. Sadiku
Y. Lemmer
S. J. Owonubi
S. S. Ray
E. Mukwevho
机构：
[1] North-West University,Department of Biological Science
[2] University of Fort Hare,Department of Chemistry
[3] Tshwane University of Technology,Institute of Nano Engineering Research (INER) and Department of Chemical, Metallurgical and Materials Engineering
[4] CSIR Biosciences,DST/CSIR National Centre for Nanostructured Materials
[5] CSIR,Department of Applied Chemistry
[6] Council for Scientific and Industrial Research,Department of Chemistry
[7] University of Johannesburg,undefined
[8] University of Zululand,undefined
来源：
Polymer Bulletin | 2019年 / 76卷
关键词：
Breast cancer; Hydrogel; Dual-drug delivery systems; Curcumin; Doxorubicin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5011 / 5037
页数：26
相关论文
共 209 条
[1]  
Torre LA(2015)Global cancer statistics CA Cancer J Clin 65 87-108
[2]  
Bray F(2014)Conventional chemotherapy: problems and scope for combined therapies with certain herbal products and dietary supplements Austin J Mol Cell Biol 1 1-10
[3]  
Siegel RL(2012)Are there opportunities for chemotherapy in the treatment of hepatocellular cancer? J Hepatol 56 686-695
[4]  
Mondal J(2009)Combination therapy: opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines Adv Drug Deliv Rev 61 1203-1213
[5]  
Panigrahi AK(2013)Different strategies to overcome multidrug resistance in cancer Biotechnol Adv 31 1397-1407
[6]  
Khuda-Bukhsh AR(2014)Doxorubicin nanoconjugates J Nanosci Nanotechnol 14 892-904
[7]  
Asghar U(2011)Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma Mol Cancer 10 12-15
[8]  
Meyer T(2011)Coformulation of doxorubicin and curcumin in poly ( Mol Pharm 8 852-866
[9]  
Greco F(2018), Food Sci Hum Wellness 7 134-137
[10]  
Vicent MJ(2015)-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells Anticancer Res 35 645-651
12345678910